Followers | 34 |
Posts | 2817 |
Boards Moderated | 0 |
Alias Born | 09/23/2006 |
Wednesday, November 16, 2016 7:11:48 PM
Mean Comp. Multiples:
TEV/Revenues (LTM):6.3x
TEV/EBITDA (LTM): 28.2x
TEV/EBIT (LTM): 23.1x
P/E: 32x
TEV/Forward Revenue (NTM): 5.82x
Obviously these multiples should be discounted to take into account the higher risk, smaller size and lower liquidity of TPNL (since the Comp list does include a long list with some of the bigger guys in the payment processing space a few of the comps included are: AMEX, VISA, MC, GPN, PLPM, CCN, VPY, WEX, CASS, etc...)
I remember doing some research on this space last year and most takeovers were occurring at 5-10x multiples on revenue. I personally prefer EBITDA multiples as a good proxy for valuing companies.
If we use the approximate EBITDA this Q of ~650k annualized*4=2.6M
Than Apply 15x multiple to be conservative (15*2.6M)=39M/43M shares= 0.91 cents or if you wanted to bump it up to 20 times (still well below most comps) it would give us (15*2.6M=52M/43M shares= $1.21 per share.
Otherwise, using a revenue multiple of 4 times to be conservative using 2.86M*4=11.25M *4x=45M/43M shares would give us $ 1.05 per share. (which is quite reasonable given most takeovers have been recorded at 5-10x revenue.
Finally using a P/E ratio, The company can realistically hit 0.05 eps/yr if not more if we see good growth (Q4 is typically strong).
Applying a 15x multiple (about a 50% discount to current mean multiples) would place the stock at 0.75$/ share. I think a 15x P/E is quite realistic given the multiples that are currently in the card payment processing space.
Its always good to use multiple valuation methods but as you can see, using conservative/reasonable metrics it would not be out of the realm of possibilities to see this stock trade over 50 cents or even towards 1$. Obviously these valuations include only the current company data if the Company lands any bigger contracts or expands in any material way the upside could change drastically.
I am holding long and strong well into 2017 to see how this materializes itself.
Recent PAYS News
- Paysign to Host First Quarter 2024 Earnings Call • Business Wire • 04/09/2024 08:30:00 PM
- Paysign, Inc. to Sponsor the 2024 International Plasma Protein Congress April 16-17 • Business Wire • 03/14/2024 08:30:00 PM
- Paysign, Inc. Reinforces Payment Processing Acumen With New Executive Hire • Business Wire • 03/13/2024 08:30:00 PM
- Paysign, Inc. to Sponsor the 2024 Gene Therapy for Rare Disorders Conference March 26-29 • Business Wire • 03/12/2024 08:30:00 PM
- Paysign Inc. to Sponsor the 2024 ACCESS USA Conference March 19-21 • Business Wire • 03/11/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:22:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:14:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 01:07:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 12:51:22 PM
- Paysign to Host Fourth Quarter and Full Year 2023 Earnings Call • Business Wire • 02/27/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:01:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 10:55:56 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 05:36:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 11:50:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 11:44:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 11:57:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 11:49:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 12:50:43 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 12:26:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 12:03:20 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 12:56:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:00:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 09:44:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM